Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML)

Published:2005-08 Issue:8 Volume:29 Page:971-973
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ali Rıdvan,Özkalemkaş Fahir,Özçelik Tülay,Özkocaman Vildan,Ozan Ülkü,Kimya Yalçın,Köksal Nilgün,Gülten Tuna,Yakut Tahsin,Tunalı Ahmet

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference10 articles.

1. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature;Ali;Jpn J Clin Oncol,2004

2. Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission;Mauro;Leuk Res,2004

3. Discontinuation of imatinib therapy after achieving a molecular response;Cortes;Blood,2004

4. Imatinib treatment: specific issues related to safety, fertility, and pregnancy;Hensley;Semin Hematol,2003

5. Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis;Ali;Ann Hematol,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding;Clinical Cancer Research;2024-07-05

2. SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: “Per Aspera Ad Astra”;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer;Journal of Clinical Medicine;2022-03-24

4. Chronic Myeloid Leukemia and Pregnancy: “Per Aspera Ad Astra”;Clinical Lymphoma Myeloma and Leukemia;2021-09

5. Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia;Iraqi Journal of Hematology;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3